300
Participants
Start Date
October 2, 2019
Primary Completion Date
October 2, 2024
Study Completion Date
October 2, 2024
Percutaneous device closure
If there is no relevant AF detected for 6 months during intermittent follow-up or ICM, device closure of PFO is recommended for high-risk PFOs but is decided ultimately at the discretion of the attending physician. If there is any relevant AF identified from ICM or other modalities during follow-up, adequate secondary prevention with anticoagulants should be carried out. All this process and decision making should be a part of routine clinical practice.
RECRUITING
Asan Medical Center, Seoul
Lead Sponsor
Collaborators (1)
Medtronic
INDUSTRY
Asan Medical Center
OTHER